Every company we cover
Fundamentals for large US-listed businesses, straight from their SEC filings.
- 11 sectors
- SEC-sourced
Health Care vs S&P 500
Combined market value of the — companies we cover, as % change over the past year.
- Change 1Y
- —
- S&P 500
- —
- Today
- +0.0%
- Market cap
- $5.59T
- Median growth · P/E
- +7.3% · 28.2×
- Health Care
- S&P 500 (SPY)
Loading…
24 of 191 match
| Ticker | Sector | 1Y trend | ||||||
|---|---|---|---|---|---|---|---|---|
| Eli Lilly | LLY | Health Care | $1,281.91 | +0.2% | $1.21T | +49.6% | 22.8% | |
| Johnson & Johnson | JNJ | Health Care | $268.73 | +0.9% | $647B | +7.8% | 20.7% | |
| AbbVie | ABBV | Health Care | $286.39 | −0.1% | $506B | +10.4% | 28.3% | |
| UnitedHealth Group | UNH | Health Care | $410.39 | −0.1% | $368B | +6.5% | 5.2% | |
| Merck | MRK | Health Care | $141.82 | +0.9% | $350B | +4.6% | 24.1% | |
| Thermo Fisher Scientific | TMO | Health Care | $693.02 | +1.2% | $256B | +7.2% | 15.8% | |
| Amgen | AMGN | Health Care | $447.95 | +0.7% | $242B | +9.1% | 26.7% | |
| Gilead Sciences | GILD | Health Care | $159.08 | +0.2% | $197B | +5.5% | 42.5% | |
| Abbott Laboratories | ABT | Health Care | $103.10 | −1.7% | $180B | +6.6% | 16.3% | |
| Pfizer | PFE | Health Care | $29.80 | +0.0% | $170B | −0.2% | 17.2% | |
| Danaher | DHR | Health Care | $232.00 | −0.4% | $163B | +5.5% | 22.4% | |
| Intuitive Surgical | ISRG | Health Care | $445.88 | −1.3% | $155B | +20.5% | 31.1% | |
| Vertex Pharmaceuticals | VRTX | Health Care | $521.03 | +0.7% | $132B | +10.2% | 30.2% | |
| Bristol-Myers Squibb | BMY | Health Care | $61.55 | −0.1% | $126B | +3.1% | 23.3% | |
| Medtronic | MDT | Health Care | $93.95 | −0.9% | $120B | +9.8% | 16.3% | |
| CVS Health | CVS | Health Care | $91.13 | −1.5% | $117B | +7.4% | 2.8% | |
| Stryker | SYK | Health Care | $301.42 | −1.5% | $116B | +8.5% | 18.2% | |
| HCA Healthcare | HCA | Health Care | $449.96 | −3.3% | $99.8B | +6.7% | 10.4% | |
| Elevance Health | ELV | Health Care | $421.49 | −2.3% | $91.1B | +3.6% | 3.2% | |
| Regeneron Pharmaceuticals | REGN | Health Care | $816.10 | +1.0% | $84.0B | +9.3% | 24.2% |
Showing 1–20 of 24
Not investment advice.